GI Innovation, Inc. (358570.KQ)
KRW 9790.0
(-4.39%)
KRW 9790.0
(-4.39%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.31 Billion KRW | 51.97% |
| 2022 | 3.5 Billion KRW | -37.5% |
| 2021 | 5.6 Billion KRW | -49.17% |
| 2020 | 11.01 Billion KRW | 213.55% |
| 2019 | 3.51 Billion KRW | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - KRW | -100.0% |
| 2024 Q1 | 24.28 Million KRW | -99.49% |
| 2023 Q4 | 4.73 Billion KRW | 0.0% |
| 2023 Q3 | - KRW | -100.0% |
| 2023 FY | 5.31 Billion KRW | 51.97% |
| 2023 Q2 | 587.89 Million KRW | 0.0% |
| 2023 Q1 | - KRW | 0.0% |
| 2022 Q2 | - KRW | 0.0% |
| 2022 FY | 3.5 Billion KRW | -37.5% |
| 2022 Q4 | - KRW | -100.0% |
| 2022 Q3 | 3.5 Billion KRW | 0.0% |
| 2022 Q1 | - KRW | -100.0% |
| 2021 FY | 5.6 Billion KRW | -49.17% |
| 2021 Q4 | 100 Million KRW | -98.18% |
| 2021 Q3 | 5.5 Billion KRW | 0.0% |
| 2020 FY | 11.01 Billion KRW | 213.55% |
| 2019 FY | 3.51 Billion KRW | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| HLB Co., Ltd. | 42.9 Billion KRW | 87.602% |
| iNtRON Biotechnology, Inc. | 9.58 Billion KRW | 44.511% |
| BINEX Co., Ltd. | 154.82 Billion KRW | 96.565% |
| Bioneer Corporation | 263.23 Billion KRW | 97.979% |
| Anterogen.Co.,Ltd. | 6.5 Billion KRW | 18.175% |
| MEDIPOST Co., Ltd. | 68.64 Billion KRW | 92.251% |
| CrystalGenomics, Inc. | 4.87 Billion KRW | -9.023% |
| Helixmith Co., Ltd | 4.2 Billion KRW | -26.59% |
| Chabiotech Co.,Ltd. | 953.95 Billion KRW | 99.442% |
| Medy-Tox Inc. | 221.12 Billion KRW | 97.595% |
| Peptron, Inc. | 3.34 Billion KRW | -59.157% |
| Amicogen, Inc. | 159.9 Billion KRW | 96.674% |
| Genexine, Inc. | 4.42 Billion KRW | -20.156% |
| HLB Therapeutics Co.,Ltd. | 53.74 Billion KRW | 90.104% |
| LegoChem Biosciences, Inc. | 34.14 Billion KRW | 84.423% |
| ALTEOGEN Inc. | 96.52 Billion KRW | 94.49% |
| PharmaResearch Co., Ltd. | 261.01 Billion KRW | 97.962% |
| SillaJen, Inc. | 3.93 Billion KRW | -35.011% |
| JETEMA, Co., Ltd. | 58.71 Billion KRW | 90.941% |
| OliX Pharmaceuticals,Inc | 17.06 Billion KRW | 68.83% |
| Genomictree Inc. | 3.41 Billion KRW | -55.612% |
| MedPacto, Inc. | - KRW | -Infinity% |
| D&D Pharmatech | 18.67 Billion KRW | 71.522% |
| EASY BIO,Inc. | 165.38 Billion KRW | 96.784% |